select a format

Single User License
USD 2000 INR 128900
Site License
USD 4000 INR 257800
Corporate User License
USD 6000 INR 386700

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Pemphigus-Pipeline Review, H1 2015

Pemphigus-Pipeline Review, H1 2015


  • Products Id :- GMDHC6314IDB
  • |
  • Pages: 68
  • |
  • February 2015
  • |
  • |
  Request for Sample Report

Executive Summary

Pemphigus-Pipeline Review, H1 2015

Summary

Global Markets Direct's, 'Pemphigus-Pipeline Review, H1 2015', provides an overview of the Pemphigus's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Pemphigus, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Pemphigus and special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global therapeutic landscape of Pemphigus

The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

The report reviews key players involved in the therapeutics development for Pemphigus and enlists all their major and minor projects

The report summarizes all the dormant and discontinued pipeline projects

A review of the Pemphigus products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

A detailed assessment of monotherapy and combination therapy pipeline projects

Coverage of the Pemphigus pipeline on the basis of target, MoA, route of administration and molecule type

Latest news and deals relating related to pipeline products

Reasons To Buy

Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop strategic initiatives by understanding the focus areas of leading companies

Identify and understand important and diverse types of therapeutics under development for Pemphigus

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Devise corrective measures for pipeline projects by understanding Pemphigus pipeline depth and focus of Indication therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Global Markets Direct Report Coverage 6

Pemphigus Overview 7

Therapeutics Development 8

Pipeline Products for Pemphigus-Overview 8

Pipeline Products for Pemphigus-Comparative Analysis 9

Pemphigus-Therapeutics under Development by Companies 10

Pemphigus-Therapeutics under Investigation by Universities/Institutes 11

Pemphigus-Pipeline Products Glance 12

Late Stage Products 12

Clinical Stage Products 13

Early Stage Products 14

Unknown Stage Products 15

Pemphigus-Products under Development by Companies 16

Pemphigus-Products under Investigation by Universities/Institutes 17

Pemphigus-Companies Involved in Therapeutics Development 18

Clinuvel Pharmaceuticals Limited 18

Genmab A/S 19

HanAll Biopharma Co., Ltd. 20

Immunomedics, Inc. 21

Momenta Pharmaceuticals, Inc. 22

Novartis AG 23

PinCell srl 24

Pemphigus-Therapeutics Assessment 25

Assessment by Monotherapy Products 25

Assessment by Target 26

Assessment by Mechanism of Action 28

Assessment by Route of Administration 30

Assessment by Molecule Type 32

Drug Profiles 34

afamelanotide-Drug Profile 34

Product Description 34

Mechanism of Action 34

R&D Progress 34

Antibody for Autoimmune Disorders and Inflammation-Drug Profile 36

Product Description 36

Mechanism of Action 36

R&D Progress 36

DP-C006-Drug Profile 37

Product Description 37

Mechanism of Action 37

R&D Progress 37

Drugs to Target HSP27 for Autoimmune Disorders-Drug Profile 38

Product Description 38

Mechanism of Action 38

R&D Progress 38

HL-161-Drug Profile 39

Product Description 39

Mechanism of Action 39

R&D Progress 39

ofatumumab-Drug Profile 40

Product Description 40

Mechanism of Action 40

R&D Progress 40

PC-111-Drug Profile 45

Product Description 45

Mechanism of Action 45

R&D Progress 45

VAY-736-Drug Profile 46

Product Description 46

Mechanism of Action 46

R&D Progress 46

veltuzumab-Drug Profile 48

Product Description 48

Mechanism of Action 48

R&D Progress 48

Pemphigus-Recent Pipeline Updates 51

Pemphigus-Dormant Projects 60

Pemphigus-Product Development Milestones 61

Featured News & Press Releases 61

Nov 21, 2014: Immunomedics Announces Orphan Drug Designation for Veltuzumab for the Treatment of Pemphigus 61

Oct 07, 2014: Stiefel, a GSK company, announces start of phase III study of subcutaneous ofatumumab for pemphigus vulgaris 61

May 22, 2014: Scenesse receives US orphan-drug designation in Hailey-Hailey Disease 62

May 19, 2014: Afamelanotide 16mg recognised for potential to treat rare Hailey-Hailey Disease 63

Feb 10, 2014: Phase II study of SCENESSE in rare skin disorder Hailey-Hailey Disease commences 63

Oct 28, 2013: Positive pilot data published on SCENESSE in rare skin disorder 64

Jul 04, 2013: Genmab Collaborator GSK Starts New Ofatumumab Phase III Study in Rare Skin Disorder 65

Appendix 67

Methodology 67

Coverage 67

Secondary Research 67

Primary Research 67

Expert Panel Validation 67

Contact Us 67

Disclaimer 68

List of Tables

Number of Products under Development for Pemphigus, H1 2015 8

Number of Products under Development for Pemphigus-Comparative Analysis, H1 2015 9

Number of Products under Development by Companies, H1 2015 10

Number of Products under Investigation by Universities/Institutes, H1 2015 11

Comparative Analysis by Late Stage Development, H1 2015 12

Comparative Analysis by Clinical Stage Development, H1 2015 13

Comparative Analysis by Early Stage Development, H1 2015 14

Comparative Analysis by Unknown Stage Development, H1 2015 15

Products under Development by Companies, H1 2015 16

Products under Investigation by Universities/Institutes, H1 2015 17

Pemphigus-Pipeline by Clinuvel Pharmaceuticals Limited, H1 2015 18

Pemphigus-Pipeline by Genmab A/S, H1 2015 19

Pemphigus-Pipeline by HanAll Biopharma Co., Ltd., H1 2015 20

Pemphigus-Pipeline by Immunomedics, Inc., H1 2015 21

Pemphigus-Pipeline by Momenta Pharmaceuticals, Inc., H1 2015 22

Pemphigus-Pipeline by Novartis AG, H1 2015 23

Pemphigus-Pipeline by PinCell srl, H1 2015 24

Assessment by Monotherapy Products, H1 2015 25

Number of Products by Stage and Target, H1 2015 27

Number of Products by Stage and Mechanism of Action, H1 2015 29

Number of Products by Stage and Route of Administration, H1 2015 31

Number of Products by Stage and Molecule Type, H1 2015 33

Pemphigus Therapeutics-Recent Pipeline Updates, H1 2015 51

Pemphigus-Dormant Projects, H1 2015 60

List of Figures

Number of Products under Development for Pemphigus, H1 2015 8

Number of Products under Development for Pemphigus-Comparative Analysis, H1 2015 9

Number of Products under Development by Companies, H1 2015 10

Comparative Analysis by Early Stage Products, H1 2015 14

Assessment by Monotherapy Products, H1 2015 25

Number of Products by Top 10 Targets, H1 2015 26

Number of Products by Stage and Top 10 Targets, H1 2015 27

Number of Products by Top 10 Mechanism of Actions, H1 2015 28

Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015 29

Number of Products by Top 10 Routes of Administration, H1 2015 30

Number of Products by Stage and Top 10 Routes of Administration, H1 2015 31

Number of Products by Top 10 Molecule Types, H1 2015 32

Number of Products by Stage and Top 10 Molecule Types, H1 2015 33

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Clinuvel Pharmaceuticals Limited

Genmab A/S

HanAll Biopharma Co., Ltd.

Immunomedics, Inc.

Momenta Pharmaceuticals, Inc.

Novartis AG

PinCell srl

Pemphigus Therapeutic Products under Development, Key Players in Pemphigus Therapeutics, Pemphigus Pipeline Overview, Pemphigus Pipeline, Pemphigus Pipeline Assessment


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com